Sage Journals: Discover world-class research

Open access

Review article

First published 2009

A Review of Trastuzumab-Based Therapy in Patients with HER2-positive Metastatic Breast Cancer

David N. Church, Chris G.A. Price

Clinical Medicine Insights: Therapeutics

Open access

Review article

First published 2024

Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options

Sarah K Premji, Ciara C O’Sullivan

Breast Cancer: Basic and Clinical Research

Retricted access

Review article

First published 2019-5

Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Kaitlin Rascon, Goran Flajc, Carmine De Angelis [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2014-07

Efficacy of Trastuzumab in Unselected Patients with HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis

Elena Collovà, Antonella Ferzi, Giuseppa Scandurra [...]

Tumori Journal

Open access

Review article

First published 2023

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2012-01

Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single Institution Experience

Diana Crivellari, Simon Spazzapan, Davide Lombardi [...]

Tumori Journal

Retricted access

Research article

First published 2024-10

Late-onset cardiotoxicity in patients with HER2-positive metastatic breast cancer receiving trastuzumab-based therapy

Shuroug A. Alowais, Samantha O. Luk, E. Bridget Kim [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Real-world analysis of HER2-ultralow in HR+/HER2– metastatic breast cancer: prevalence and first-line chemotherapy outcomes

Laurent Mathiot, Olivier Kerdraon, Florent Le Borgne [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China

Xinzhao Wang, Lin Wang, Qian Yu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2026

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

Taha Koray Sahin, Fatih Kemik, Harun Muglu [...]

Therapeutic Advances in Medical Oncology

Search results